Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Assets (2016 - 2025)

United Therapeutics' Return on Assets history spans 16 years, with the latest figure at 0.18% for Q4 2025.

  • For Q4 2025, Return on Assets rose 1.0% year-over-year to 0.18%; the TTM value through Dec 2025 reached 0.18%, up 1.0%, while the annual FY2025 figure was 0.18%, 1.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.18% at United Therapeutics, up from 0.17% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.18% in Q4 2025 and bottomed at 0.09% in Q1 2021.
  • The 5-year median for Return on Assets is 0.13% (2023), against an average of 0.13%.
  • The largest annual shift saw Return on Assets dropped -5bps in 2021 before it rose 4bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.09% in 2021, then surged by 32bps to 0.12% in 2022, then increased by 13bps to 0.14% in 2023, then increased by 19bps to 0.16% in 2024, then increased by 6bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Return on Assets are 0.18% (Q4 2025), 0.17% (Q3 2025), and 0.16% (Q2 2025).